Neovacs S.A.
ENXTPA:ALNEV
0.27
-0.06€ (-18.18%)
0.27
-0.06€ (-18.18%)
End-of-day quote: 05/02/2024

ALNEV - Neovacs Stock Prediction 2025 - 2030

15 years of reliable Neovacs stock forecast. The Wall Street analysts predict Data Unavailable for ALNEV. See at a glance whether ENXTPA:ALNEV will rise in the future.

Forecast 2023
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
Forecast 2030
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
-,868.47
Price-to-book Ratio
N/A
Market Cap
0.00B
TEV
-0.03 B
Dividend
0.00€
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
32,000,000.00€
Country
Website

Neovacs Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Neovacs Stock Forecast 2023

0.00€

In the last five quarters, Neovacs’s Price Target has risen from 32,000,000.00€ to 32,000,000.00€ - a 0% increase.

-100%
-100
Last update: 05/03/2024

Highest Price Target 0.00€

Average Price Target 0.00€

Lowest Price Target 0.00€

Neovacs Stock Forecast 2025

Neovacs Stock Predictions 2030

P/E
0.00
Beta
-,868.47
Price-to-book Ratio
N/A
Market Cap
0.00B
TEV
-0.03 B
Dividend
0.00€
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
32,000,000.00€
Country
Website

Neovacs Analyst Ratings Frequently Asked Questions

Who are the analysts watching Neovacs S.A.?

The following analysts have recently covered Neovacs:

Data Unavailable
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Neovacs S.A.?

The following sell-side analysts have recently covered Neovacs:

Data Unavailable
(This information refers to the last 90 days.)